//U.S. launches two clinical trials for coronavirus antibody treatment

U.S. launches two clinical trials for coronavirus antibody treatment

The NIH and U.S. drug maker Eli Lilly are looking for 2,000 volunteers for antibody drug trials to treat patients suffering through the ravages of COVID-19.